Back

Real-world efficacy of bempedoic acid: early insights from the BEMPENET Italian Registry

29 August 2026 (09:15 - 09:45)
Organised by: Logo
Congress Presentation Part of: Therapeutic advancements in lipid-lowering pharmacotherapy Lipid-Lowering Agents ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ciro Cotticelli

University of Naples Federico II, Naples (Italy)

3 More presentations in this session

Presentation thumbnail
Understanding discrepancies in trial-level surrogacy of LDL-cholesterol reduction for cardiovascular risk: a methodological appraisal and updated meta-regression
Doctor G. Chen (Zurich, CH)
Abstract Slides
Presentation thumbnail
An inclisiran-based treatment strategy reduces the need for therapy escalation to achieve low-density lipoprotein cholesterol goals: Exploratory findings from the VICTORION-Difference trial
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Bempedoic acid for LDL-cholesterol management in patients with and without diabetes: insights from the MILOS study
Professor T. Stulnig (Vienna, AT)
Abstract Slides

Access the full session

Session thumbnail
Therapeutic advancements in lipid-lowering pharmacotherapy

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of bempedoic acid alone and combined with ezetimibe on ldl-cholesterol reduction: graphical evidence and retrospective analysis of a real-world clinical cohort
24 April 2026
thumbnail
Congress Presentation
Use of inclisiran in a real-world setting: results from the italian Cholinet registry
28 August 2023
thumbnail
Congress Presentation
The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe
28 August 2022
thumbnail
Congress Presentation
Comparative effectiveness of novel anti-hyperlipidemic drugs in adults with hyperlipidemia: a systematic review and bayesian network meta-analysis
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources